BUZZ-DB rearranges ratings on European staples

Reuters01-13
BUZZ-DB rearranges ratings on European staples

** Deutsche Bank analysts reshuffle their ratings on European consumer staples, downgrading Danone DANO.PA, Haleon HLN.L and Barry Callebaut BARN.S while upgrading Beiersdorf BEIG.DE and L'Oreal OREP.PA

** The analysts say that while lots of negative factors have been priced in within the sector, the market backdrop still remains difficult, and cut ratings for companies which stock prices over-estimate future growth

** DB expect the consumers equities in 2026 will be most impacted by the shift of sales channel to Amazon, rivalry with niche players, and increasing divide between low-, and high-income customers

** It cites an expected a slowdown in the US health and wellness trend and protein consumption as a reason for the Danote cut

** DB notes Haleon is seen as highly exposed to the channel shift from drug stores to Amazon in North America

** In contrast, it favours the German personal care company Beiersdorf on a likely turnaround and priced-in potential risks

** DB also upgrades French cosmetics maker L'Oreal to "hold" from "sell", noting that potential hit to stock from growth risks seem limited

COMPANY

RATING

OLD RATING

PT

OLD PT

BARRY CALLEBAUT

SELL

HOLD

UNCHANGED

CHF 1000.00

DANONE

SELL

HOLD

EUR 67.00

EUR 74.00

HALEON

SELL

HOLD

GBP 3.40

GBP 3.60

L'OREAL

HOLD

SELL

EUR 360.00

EUR 340.00

BEIERSDORF

BUY

HOLD

EUR 105.00

EUR 98.00

(Reporting by Mateusz Rabiega)

((Mateusz.rabiega@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment